Drilling into the Technicals & Valuation For Walgreens Boots Alliance, Inc. (NasdaqGS:WBA)

Postado Dezembro 07, 2017

The Shareholder Yield (Mebane Faber) of Walgreens Boots Alliance, Inc. This buyback authorization permits the pharmacy operator to repurchase shares of its stock through open market purchases. The Gross Margin Score of Walgreens Boots Alliance, Inc. Commonwealth Bank of Australia raised its stake in Walgreens Boots Alliance by 139.5% during the second quarter. Nordea Investment Management AB now owns 9,154,328 shares of the pharmacy operator's stock valued at $760,267,000 after buying an additional 1,917,082 shares in the last quarter. Reilly Financial Advisors LLC grew its position in shares of Walgreens Boots Alliance by 7.9% in the second quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator's stock valued at $2,727,932,000 after buying an additional 1,824,300 shares in the last quarter. S&P Research maintained Walgreens Boots Alliance, Inc. The stock increased 0.17% or $0.12 during the last trading session, reaching $70.3.

(NASDAQ:WBA) has noticeable measure of stock volatility, for this average true range is an exponential moving average (14 trading days) of the True Ranges. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07. Needham maintained Walgreens Boots Alliance, Inc. They expect $1.25 EPS, down 28.98% or $0.51 from last year's $1.76 per share. Calculated by dividing Walgreens Boots Alliance, Inc.'s annual earnings by its total assets, investors will note a return on assets of 5.70%. (NASDAQ:WBA) Earnings Growing Rapidly? Walgreens is acquiring the stake for about 2.767 billion yuan ($418 million), the company said. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The firm had revenue of $29.45 billion during the quarter, compared to analyst estimates of $30.17 billion. During the same period in the prior year, the business posted $1.07 earnings per share. sell-side analysts predict that Walgreens Boots Alliance Inc will post 5.55 EPS for the current fiscal year. SunTrust has "Hold" rating and $72.0 target. The ex-dividend date of this dividend is Friday, November 10th. Following the transaction, the director now directly owns 50,000 shares in the company, valued at approximately $3,350,000. Walgreens Boots Alliance's payout ratio is now 39.68%. Following the completion of the sale, the director now owns 16,415 shares in the company, valued at $1,105,878.55. Andra AP fonden now owns 58,300 shares of the pharmacy operator's stock worth $4,565,000 after purchasing an additional 15,200 shares during the period. Shares buyback programs are typically an indication that the company's leadership believes its stock is undervalued.

Several equities analysts recently issued reports on WBA shares. Guggenheim reaffirmed a "buy" rating and set a $100.00 target price on shares of Walgreens Boots Alliance in a report on Thursday, April 6th. They issued a "hold" rating and a $78.00 price target on the stock. Loop Capital initiated coverage on Walgreens Boots Alliance in a report on Thursday, August 24th. BidaskClub raised shares of Walgreens Boots Alliance from a "sell" rating to a "hold" rating in a research note on Wednesday, August 30th. The fund owned 2,884 shares of the pharmacy operator's stock after selling 43 shares during the period. The stock was sold at an average price of $85.89, for a total transaction of $234,995.04. Insiders own 13.50% of the company's stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

In other news, Director John Anthony Lederer acquired 20,000 shares of the business's stock in a transaction that occurred on Thursday, October 26th.

COPYRIGHT VIOLATION NOTICE: "Walgreens Boots Alliance Inc (WBA) Holdings Trimmed by Sprucegrove Investment Management Ltd." was published by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are accessing this news story on another site, it was illegally copied and reposted in violation of U.S. & global copyright and trademark law. GuoDa operates and franchises 3,500 retail pharmacies across China. The Company's products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).